Cargando…
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161151/ https://www.ncbi.nlm.nih.gov/pubmed/34065216 http://dx.doi.org/10.3390/jcm10102208 |
_version_ | 1783700442832699392 |
---|---|
author | Funuyet-Salas, Jesús Martín-Rodríguez, Agustín Pérez-San-Gregorio, María Ángeles Romero-Gómez, Manuel |
author_facet | Funuyet-Salas, Jesús Martín-Rodríguez, Agustín Pérez-San-Gregorio, María Ángeles Romero-Gómez, Manuel |
author_sort | Funuyet-Salas, Jesús |
collection | PubMed |
description | Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined whether self-efficacy exerted a moderating role in these associations. QoL (SF-12), social support (MSPSS), depressive symptoms (HADS), self-efficacy (GSE), physical activity (IPAQ) and diet (MEDAS) were evaluated in 413 biopsy-proven NAFLD patients. Mediation and moderated mediation models were conducted using the SPSS PROCESS v3.5 macro. Results showed that depressive symptoms mediated the relationship between physical QoL and adherence to physical activity (indirect effect = 6.248, CI = 1.917–10.727), as well as the relationship between social support and adherence to diet (indirect effect = 0.148, CI = 0.035–0.275). Self-efficacy also moderated the indirect effects of QoL and social support on therapeutic adherence through depressive symptoms. Specifically, the higher self-efficacy was, the lower the negative impact on the NAFLD patient’s mental health. In conclusion, self-efficacy is defined as a protective factor for therapeutic adherence by NAFLD patients with a psychosocial risk profile. Self-efficacy should, therefore, be a main psychological target in future multidisciplinary NAFLD approaches. |
format | Online Article Text |
id | pubmed-8161151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81611512021-05-29 Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model Funuyet-Salas, Jesús Martín-Rodríguez, Agustín Pérez-San-Gregorio, María Ángeles Romero-Gómez, Manuel J Clin Med Article Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined whether self-efficacy exerted a moderating role in these associations. QoL (SF-12), social support (MSPSS), depressive symptoms (HADS), self-efficacy (GSE), physical activity (IPAQ) and diet (MEDAS) were evaluated in 413 biopsy-proven NAFLD patients. Mediation and moderated mediation models were conducted using the SPSS PROCESS v3.5 macro. Results showed that depressive symptoms mediated the relationship between physical QoL and adherence to physical activity (indirect effect = 6.248, CI = 1.917–10.727), as well as the relationship between social support and adherence to diet (indirect effect = 0.148, CI = 0.035–0.275). Self-efficacy also moderated the indirect effects of QoL and social support on therapeutic adherence through depressive symptoms. Specifically, the higher self-efficacy was, the lower the negative impact on the NAFLD patient’s mental health. In conclusion, self-efficacy is defined as a protective factor for therapeutic adherence by NAFLD patients with a psychosocial risk profile. Self-efficacy should, therefore, be a main psychological target in future multidisciplinary NAFLD approaches. MDPI 2021-05-20 /pmc/articles/PMC8161151/ /pubmed/34065216 http://dx.doi.org/10.3390/jcm10102208 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Funuyet-Salas, Jesús Martín-Rodríguez, Agustín Pérez-San-Gregorio, María Ángeles Romero-Gómez, Manuel Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title | Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title_full | Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title_fullStr | Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title_full_unstemmed | Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title_short | Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model |
title_sort | influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: a moderated mediation model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161151/ https://www.ncbi.nlm.nih.gov/pubmed/34065216 http://dx.doi.org/10.3390/jcm10102208 |
work_keys_str_mv | AT funuyetsalasjesus influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel AT martinrodriguezagustin influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel AT perezsangregoriomariaangeles influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel AT romerogomezmanuel influenceofpsychologicalbiomarkersontherapeuticadherencebypatientswithnonalcoholicfattyliverdiseaseamoderatedmediationmodel |